Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network

Activity Overview

The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

Course Curriculum

Click below to view the available video interviews.  Check back weekly for newly released content!

The Four Components of A Successful Clinical Trial Network

Sowing Seeds and Building New Programs

Sustainability and Lessons Learned

Presenters


Thomas J. Herzog, MD
University of Cincinnati, Cincinnati, Ohio, USA

Sharyn Lewin, MD, FACS, FACOG
Director, Division of Gynecologic Oncology,
Holy Name Medical Center

Released Friday, June 4, 2021

Quality Management Processes – Small Sites Part 1

Presenters


Thomas J. Herzog, MD
University of Cincinnati, Cincinnati, Ohio, USA


Destin Black, MD
Professor of Clinical Obstetrics and Gynecology, Director, Division of Gynecologic Oncology, Louisiana State University Health Shreveport, Willis-Knighton Medical Center

Carrie Kay, RN, CCRC
Willis-Knighton Medical Center Physician Network Clinical Research Manager

Released Friday, June 11, 2021

Quality Management Processes – Small Sites Part 2

Enrollment and Accrual

Quality Management Processes – Large Sites

Budget and Contract Management; Strategic Insights on Maneuvering Through your Legal and Finance Discussions

The Ten Keys to Success When Building Your Clinical Trial Network

Research Algorithms, Clinical Trial Prioritization(s), Sequencing of Trials/Treatment

Inclusion in Clinical Trials

2021 Cervix Portfolio Year End Review

2021 Ovarian Portfolio Year End Review

NEW – 2021 Endometrial Portfolio Year End Review

Presenters


Brian Slomovitz, MD
Mount Sinai Medical Center, Miami Beach, Florida, USA

Angeles Alvarez Secord, MD, MHSc
Duke Cancer Center Institute, Durham, North Carolina, USA

Released Thursday, December 30, 2021